We consider a tight-binding model on the honeycomb lattice in a magnetic field. For special values of the hopping integrals, the dispersion relation is linear in one direction and quadratic in the other. We find that, in this case, the energy of the Landau levels varies with the field B as epsilon(n)(B) ~ [(n+gamma)B](2/3). This result is obtained from the low-field study of the tight-binding spectrum on the honeycomb lattice in a magnetic field (Hofstadter spectrum) as well as from a calculation in the continuum approximation at low field. The latter links the new spectrum to the one of a modified quartic oscillator. The obtained value gamma=1/2 is found to result from the cancellation of a Berry phase.
We study the transition from ballistic to diffusive and localized transport in graphene nanoribbons in the presence of binary disorder, which can be generated by chemical adsorbates or substitutional doping. We show that the interplay between the induced average doping ͑arising from the nonzero average of the disorder͒ and impurity scattering modifies the traditional picture of phase-coherent transport. Close to the Dirac point, intrinsic evanescent modes produced by the impurities dominate transport at short lengths giving rise to a regime analogous to pseudodiffusive transport in clean graphene, but without the requirement of heavily doped contacts. This intrinsic pseudodiffusive regime precedes the traditional ballistic, diffusive, and localized regimes. The last two regimes exhibit a strongly modified effective number of propagating modes and a mean free path which becomes anomalously large close to the Dirac point.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.